Agents for the treatment of neurodegenerative diseases: January - June 1998

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.8, Iss.10, 1998-10, pp. : 1269-1307

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Agents for the treatment of neurodegenerative diseases: January - June 1997

By Baudy R.B.

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 10, 1997-10 ,pp. : 1129-1174

Informa Healthcare

Access to resources Recommend Favorite

Agents for the treatment of neurodegenerative diseases: July - December 1997

By Baudy R.B.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 4, 1998-04 ,pp. : 395-438

Informa Healthcare

Access to resources Recommend Favorite

Agents for the treatment of neurodegenerative diseases: July - December 1996

By Baudy R.B.

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 5, 1997-05 ,pp. : 471-509

Informa Healthcare

Access to resources Recommend Favorite

Chelating Agents for Neurodegenerative Diseases

Current Medicinal Chemistry, Vol. 19, Iss. 17, 2012-06 ,pp. : 2760-2772

Bentham Science Publishers

Access to resources Recommend Favorite

QSAR and Pharmacophore Study of Dyrk1A Inhibitory Meridianin Analogs as Potential Agents for Treatment of Neurodegenerative Diseases

Medicinal Chemistry, Vol. 9, Iss. 1, 2013-02 ,pp. : 152-161

Bentham Science Publishers

Access to resources Recommend Favorite